Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
Monaldi Archives for Chest Disease · 2023
DOI: 10.4081/monaldi.2023.2618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monaldi Archives for Chest Disease, 2023. Verfasst von Roshni Mary Prince und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Government Medical College, Kota. roshini4rose@gmail.com. Hauptthemen laut MEDLINE: Diarylquinolines, Antitubercular Agents, Tuberculosis, Multidrug-Resistant, Tertiary Care Centers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The emergence of drug-resistant strains of Mycobacterium tuberculosis has become a significant public health problem and has led to a setback in efforts to end tuberculosis (TB) worldwide. The longer duration, heavier pill load, and higher toxicity profile of DR-TB regimens compared to those for drug-susceptible TB (DS-TB) lead to reduced adherence and worse treatment results, including mortality. This study was conducted to estimate treatment outcomes and adverse effects in patients with drug-resistant TB patients on bedaquiline-containing regimen. Patients after the pre-treatment evaluation were enrolled for bedaquiline-containing regimen. These patients were followed up for 18 months and the final outcome was assessed along with the adverse effects. It was found that 49 (84.4%) patients achieved culture conversion by three months and 54 (93.1%) achieved culture conversion by six months, 52 (83.81%) patients had favourable outcomes (cured, treatment completed) and 10 patients had unfavourable outcomes (died, lost to follow-up, failed). Coupled with gradually increasing trends of success rates from 2012, lesser failure rates and lesser concerns regarding grave adverse effects are a silver lining along the cloud of increasing burden and widening resistance patterns. More funding has to be directed towards ensuring adherence and finding high-risk individuals in order to expedite the achievement of sustainable development (SDG) goals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Government Medical College, Kota. roshini4rose@gmail.com.
- Department of Respiratory Medicine, Government Medical College, Kota. drsharadsingh@rocketmail.com.
- Department of Respiratory Medicine, Government Medical College, Kota. qazifaizan715@gmail.com.
- Department of Respiratory Medicine, Government Medical College, Kota. Anishmittal60@gmail.com.
- Department of Respiratory Medicine, Government Medical College, Kota. drram427@gmail.com.
- Department of Respiratory Medicine, Government Medical College, Kota. gover.mansha58@gmail.com.
Zitieren
APA
Mary Prince, R., Khangarot, S., Haque, Q. F., Mittal, A., Somani, R., & Grover, M. (2023). Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2023.2618
Vancouver
Mary Prince R, Khangarot S, Haque QF, Mittal A, Somani R, Grover M. Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan. Monaldi Archives for Chest Disease. 2023. doi:10.4081/monaldi.2023.2618
BibTeX
@article{MaryPrince2023,
author = {Mary Prince, Roshni and Khangarot, Suman and Haque, Qazi Faizanul and Mittal, Anish and Somani, Ramdhan and Grover, Mansha},
title = {Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan},
journal = {Monaldi Archives for Chest Disease},
year = {2023},
doi = {10.4081/monaldi.2023.2618}
}
EUVIMED